<HashMap><database>MetaboLights</database><file_versions><headers><Content-Type>application/xml</Content-Type></headers><body><files><Tabular>ftp://ftp.ebi.ac.uk/pub/databases/metabolights/studies/public/MTBLS14031/m_MTBLS14031_LC-MS_negative_reverse-phase_metabolite_profiling_v2_maf.tsv</Tabular><Txt>ftp://ftp.ebi.ac.uk/pub/databases/metabolights/studies/public/MTBLS14031/a_MTBLS14031_LC-MS_negative_reverse-phase_metabolite_profiling.txt</Txt><Txt>ftp://ftp.ebi.ac.uk/pub/databases/metabolights/studies/public/MTBLS14031/i_Investigation.txt</Txt><Txt>ftp://ftp.ebi.ac.uk/pub/databases/metabolights/studies/public/MTBLS14031/s_MTBLS14031.txt</Txt></files><type>primary</type></body><statusCode>OK</statusCode><statusCodeValue>200</statusCodeValue></file_versions><scores/><additional><ftp_download_link>ftp://ftp.ebi.ac.uk/pub/databases/metabolights/studies/public/MTBLS14031</ftp_download_link><metabolite_identification_protocol>&lt;p>Based on the standard substances, a MWDB (Metware Database) was constructed to conduct qualitative analysis on the data detected by mass spectrometry. Quantitative is using triple level 4 pole mass spectrometry of many Reaction Monitoring mode (Multiple Reaction Monitoring, MRM, the following chart) analysis. MRM mode, the four pole first screening target substances precursor ion (female) ions, rule out other molecules corresponding ion to preliminary eliminate interference quantity material; Precursor ion after collision ionization chamber induced fracture fragment ions were formed, fragment ions by triple level 4 pole filter again choose the needed characteristic fragment ions, exclusion of target ion interference, makes quantitative more fine indeed, better repeatability. After winning the mass spectrometry data of different samples, chromatographic peak of all the target points, through the standard curve for quantitative analysis.&lt;/p></metabolite_identification_protocol><repository>MetaboLights</repository><study_status>Public</study_status><ptm_modification></ptm_modification><instrument_platform>Liquid Chromatography MS - negative - reverse-phase</instrument_platform><chromatography_protocol>&lt;p>The sample extracts were analyzed using an LC-ESI-MS/MS system. The analytical conditions were as follows, HPLC: column, ACQUITY UPLC HSS T3(1.8 µm, 100 mm x 2.1 mm; Waters); solvent system, water with 0.01% acetic acid and 5 mmol/L ammonium acetate (A), acetonitrile with 0.01% acetic acid (B); The gradient was optimized at 5% to 40%B in 1 min, then increased to 50% B in 6 min, then increased to 75% B in 5 min, and then 75% to 95% in 2min, washed with 95%B for 2 min, finally ramped back to 5% B; flow rate, 0.35 mL/min; temperature, 40°C; injection volume: 3 μL. The effluent was alternatively connected to an ESI-triple quadrupole-linear ion trap (QTRAP)-MS.&lt;/p></chromatography_protocol><publication>Glycocholic Acid Inhibits TRIB3-ID1 Axis to Destroy Intestinal Epithelial Integrity in Colitis via Suppressing Intestinal Stem Cell Renewal.</publication><submitter_name>jing liu</submitter_name><submitter_affiliation>Institute of Materia Medica</submitter_affiliation><organism_part>feces</organism_part><technology_type>mass spectrometry assay</technology_type><disease></disease><extraction_protocol>&lt;p>Samples (20 mg) were extracted with 495 μL methanol after the samples grinded with ball mill. 5μL internal standard mixed solution (10 μg/mL) was added into the extract as internal standards (IS) for the quantitation. Put the samples at -20°C for 10 min to precipitated protein. Then centrifugation for 10 min (12000 r/min, and 4°C), After centrifugation, supernatant through protein precipitation plate for further LC-MS analysis&lt;/p></extraction_protocol><organism>Mus musculus</organism><full_dataset_link>https://www.ebi.ac.uk/metabolights/MTBLS14031</full_dataset_link><data_transformation_protocol>&lt;p>The raw mass spectrometry data were converted to mzML format using ProteoWizard. The processed data were then analyzed with MultiQuant software (version 3.0.3). Chromatographic peaks of the analytes detected in different samples were integrated and corrected by referencing the retention times and peak profiles of the corresponding standards, ensuring accurate identification and quantification. Standard solutions at different concentrations were prepared, and the chromatographic peak intensities of the quantitative signals for each concentration were obtained. Standard curves for each substance were constructed by plotting the concentration of the external standard on the x-axis against the peak area ratio (Area Ratio) of the external standard to the internal standard on the y-axis. The quantitative results for the actual samples were finally obtained by substituting the measured values into the corresponding calculation formula.&lt;/p></data_transformation_protocol><study_factor>Time point</study_factor><submitter_email>liujing@imm.ac.cn</submitter_email><sample_collection_protocol>&lt;p>Acute UC model was induced in mice using 2% DSS. Fecal samples were collected from the mice on days 0, 4, and 7 post-treatment for metabolomic analysis of bile acids. The feces of mice with acute UC were taken out, frozen in liquid nitrogen and sent on dry ice.&lt;/p></sample_collection_protocol><omics_type>Metabolomics</omics_type><study_design>fecal bile acids</study_design><study_design>Mice</study_design><study_design>targeted metabolite profiling</study_design><study_design>inflammatory bowel disease</study_design><curator_keywords>fecal bile acids</curator_keywords><curator_keywords>Mice</curator_keywords><curator_keywords>targeted metabolite profiling</curator_keywords><curator_keywords>inflammatory bowel disease</curator_keywords><mass_spectrometry_protocol>&lt;p>Linear ion trap (LIT) and triple quadrupole (QQQ) scans were acquired on a triple quadrupole-linear ion trap mass spectrometer (QTRAP), QTRAP® 6500+ LC-MS/MS System, equipped with an ESI Turbo Ion-Spray interface, operating in negative ion mode and controlled by Analyst 1.6.3 software (Sciex). The ESI source operation parameters were as follows: ion source, ESI-; source temperature 550 ∘C; ion spray voltage (IS) -4500 V; curtain gas (CUR) was set at 35 psi, respectively. Bile acids were analyzed using scheduled multiple reaction monitoring (MRM). Data acquisitions were performed using Analyst 1.6.3 software (Sciex). Multiquant 3.0.3 software (Sciex) was used to quantify all metabolites. Mass spectrometer parameters including the declustering potentials (DP) and collision energies (CE) for individual MRM transitions were done with further DP and CE optimization. A specific set of MRM transitions were monitored for each period according to the metabolites eluted within this period.&lt;/p></mass_spectrometry_protocol><metabolite_name>cholic acid</metabolite_name><metabolite_name>apocholic acid</metabolite_name><metabolite_name>3,7-DIKETOCHOLANIC ACID</metabolite_name><metabolite_name>Chenodeoxycholic acid-3-¦Â-D-glucuronide</metabolite_name><metabolite_name>7-ketolithocholic acid</metabolite_name><metabolite_name>Ursocholic acid</metabolite_name><metabolite_name>Tauroursodeoxycholic acid</metabolite_name><metabolite_name>12-ketolithocholic acid</metabolite_name><metabolite_name>Glycochenodeoxycholic Acid 3 Sulfate Disodium Salt</metabolite_name><metabolite_name>Glycocholic acid</metabolite_name><metabolite_name>Dehydrocholic acid</metabolite_name><metabolite_name>Lithocholic acid</metabolite_name><metabolite_name>Ursodeoxycholic acid</metabolite_name><metabolite_name>Isoallolithocholic acid</metabolite_name><metabolite_name>Taurohyodeoxycholic Acid (sodium salt)</metabolite_name><metabolite_name>Glycoursodeoxycholic Acid 3 Sulfate Sodium</metabolite_name><metabolite_name>3-Oxocholic acid</metabolite_name><metabolite_name>lithocholic acid-3-sulfate</metabolite_name><metabolite_name>Cholic Acid 3 Sulfate Sodium Salt</metabolite_name><metabolite_name>Deoxycholic Acid 3-O-Sulfate Disodium Salt</metabolite_name><metabolite_name>taurolithocholic acid-3-sulfate</metabolite_name><metabolite_name>¦Á-muricholic acid</metabolite_name><metabolite_name>Deoxycholic acid 3,12-disulfate trisodium salt</metabolite_name><metabolite_name>Taurocholic acid</metabolite_name><metabolite_name>Tauro-¦Á-muricholicAcid sodium salt</metabolite_name><metabolite_name>¦Â-muricholic acid</metabolite_name><metabolite_name>norcholic acid</metabolite_name><metabolite_name>Isodeoxycholic acid</metabolite_name><metabolite_name>Tauro-¦Ø-muricholic Acid sodium salt</metabolite_name><metabolite_name>taurolithocholic acid</metabolite_name><metabolite_name>Taurohyocholic acid</metabolite_name><metabolite_name>isolithocholic acid</metabolite_name><metabolite_name>glycolithocholic acid-3-sulfate</metabolite_name><metabolite_name>LITHOCHOLENIC ACID</metabolite_name><metabolite_name>5¦Á-CHOLANIC ACID-3¦Á-OL</metabolite_name><metabolite_name>¦Â-Hyodeoxycholic Acid</metabolite_name><metabolite_name>Taurochenodeoxycholic acid</metabolite_name><metabolite_name>Chenodeoxycholic acid</metabolite_name><metabolite_name>Chenodeoxycholic acid 24-acyl-b-D-glucuronide</metabolite_name><metabolite_name>Nor-Deoxycholic Acid</metabolite_name><metabolite_name>3¦Â-Ursodeoxycholic Acid</metabolite_name><metabolite_name>TAUROURSOCHOLIC ACID</metabolite_name><metabolite_name>Lithocholic Acid 3-O-Glucuronide</metabolite_name><metabolite_name>Tauro-¦Â-muricholic acid</metabolite_name><metabolite_name>7-Ketodeoxycholic acid</metabolite_name><metabolite_name>hyocholic acid</metabolite_name><metabolite_name>Taurodeoxycholic acid</metabolite_name><metabolite_name>Taurodehydrocholic acid</metabolite_name><metabolite_name>allocholic acid</metabolite_name><metabolite_name>Dehydrolithocholic acid</metabolite_name><metabolite_name>cholic acid 7 sulfate</metabolite_name><metabolite_name>5-¦Â-Cholanic Acid-3¦Á-ol-6-one</metabolite_name><metabolite_name>3-oxochenodeoxycholic acid</metabolite_name><metabolite_name>Tauroursodeoxycholic Acid-3-Sulfate Sodium Salt</metabolite_name><metabolite_name>6,7-diketolithocholic acid</metabolite_name><metabolite_name>7,12-diketolithocholic acid</metabolite_name><metabolite_name>12-Oxochenodeoxycholic acid</metabolite_name><metabolite_name>Glycoursodeoxycholic acid</metabolite_name><metabolite_name>3¦Â-Cholic Acid</metabolite_name><metabolite_name>3,6-DIKETOCHOLANIC ACID</metabolite_name><metabolite_name>Cholic Acid 3-O-b-Glucuronide Disodium Salt</metabolite_name><metabolite_name>¦Ø-muricholic acid</metabolite_name><metabolite_name>Glycochenodeoxycholic acid</metabolite_name><metabolite_name>3¦Â-deoxycholic acid</metabolite_name><metabolite_name>3¦Â-hydroxychol-5-en-24-oic acid</metabolite_name><metabolite_name>12-dehydrocholic acid</metabolite_name><metabolite_name>Hyodeoxycholic acid</metabolite_name><metabolite_name>Deoxycholic acid</metabolite_name><metabolite_name>Chenodeoxycholic acid 3,7-disulfate trisodium salt</metabolite_name><metabolite_name>Glycohyodeoxycholic Acid</metabolite_name><metabolite_name>3-oxodeoxycholic acid</metabolite_name><metabolite_name>Glycohyocholic acid</metabolite_name><metabolite_name>murideoxycholic acid</metabolite_name><metabolite_name>Glycolithocholic acid</metabolite_name><metabolite_name>Glycodeoxycholic acid</metabolite_name><metabolite_name>Isochenodeoxycholic Acid</metabolite_name><metabolite_name>Glycodehydrocholic acid</metabolite_name><metabolite_name>chenodeoxycholic acid3-sulfate disodium salt</metabolite_name><metabolite_name>3-Sulfo-ursodeoxycholic Acid Disodium Salt</metabolite_name><metabolite_name>Taurocholic Acid 3 sulfate sodium salt</metabolite_name><metabolite_name>Trihydroxycholestanoic Acid</metabolite_name><metabolite_name>3¦Â-Glycocholic Acid</metabolite_name></additional><is_claimable>false</is_claimable><name>Measurements of fecal bile acids abundance in DSS induced UC mice model</name><description>&lt;p>Background and aims: Elevation of conjugated primary bile acid—GCA in fecal samples was reported in IBD patients compared to healthy controls (nearly 10-fold), as well as in active ulcerative colitis (UC) patients relative to those in remission stages. Therefore we wanted to investigate the potential role of GCA in colitis progression. Here, we would like to know how fecal GCA abundance changes during acute UC progression in C57BL/6J mice.&lt;/p>&lt;p>Methods: Acute UC model was induced in mice using 2% DSS. Fecal samples were collected from the mice on days 0, 4, and 7 post-treatment for metabolomic analysis of bile acids.&lt;/p></description><dates><publication>2026-05-03</publication><submission>2026-03-12</submission></dates><accession>MTBLS14031</accession><cross_references><KEGG>CDCA-3S</KEGG><KEGG>CDCA</KEGG><KEGG>CA</KEGG><KEGG>CA-7S</KEGG><KEGG>CDCA-3Gln</KEGG><KEGG>CA-3G</KEGG><KEGG>CA-3S</KEGG><KEGG>CDCA-3,7S</KEGG><KEGG>CDCA-24G</KEGG></cross_references></HashMap>